Skip To Main Content
Michael Bukhalo on Muck Rack

Michael Bukhalo

As seen in: SKIN The Journal of Cutaneous Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Michael Bukhalo’s profile

Articles by Michael Bukhalo

A Phase 3b Study Evaluating Safety and Efficacy of Risankizumab in Adult Patients with Moderate-to-Severe Plaque Psoriasis with Palmoplantar (Non-Pustular) Involvement | SKIN The Journal of Cutaneous Medicine

|
By Mark Lebwohl, Michael Bukhalo, Linda Gold, Michelle T. Pelle
| SKIN The Journal of Cutaneous Medicine Verified
Main Article Content Mark Lebwohl Michael Bukhalo Linda Stein Gold Michelle Pelle Bradley Glick Mar Llamas-Velasco Samuel Sanchez-Rivera Tianyu Zhan Leonidas Drogaris Kevin Douglas Greg St. John Ramon Espaillat Robert Bissonnette Keywords Risankizumab, Palmoplantar, Psoriasis, Biologics Abstract References 1. Trovato E, Cortonesi G, Orsini C, Capalbo E, Cinotti E, Rubegni P, Cartocci A. Anti-IL23for nail psoriasis in real life: Results of efficacy and safety during a 52-week period. Dermatol Ther.
Open in Who Shared View Duplicates (49) Issue with article?

Interim Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes | SKIN The Journal of Cutaneous Medicine

|
By Bruce E. Strober, April Armstrong, Michael Bukhalo, Arlington Dermatology
| SKIN The Journal of Cutaneous Medicine Verified
Main Article Content Keywords psoriasis, machine learning, clinical utility, biomarkers, transcriptomics, biologics Abstract Objective: This study (MATCH) was designed to assess the clinical utility of a machine-learning based tool (Mind.Px) that predicts patient response to the most common biologic drug classes used in the management of psoriasis patients. Methods: The MATCH study was designed to assess Mind.Px utility in physician decision making and patient outcomes.
Open in Who Shared Issue with article?
Show More